vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and APTARGROUP, INC. (ATR). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($982.9M vs $829.0M, roughly 1.2× Acadia Healthcare Company, Inc.). APTARGROUP, INC. runs the higher net margin — 7.4% vs 0.5%, a 6.9% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (10.8% vs 7.5%). Over the past eight quarters, APTARGROUP, INC.'s revenue compounded faster (3.9% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
ACHC vs ATR — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $982.9M |
| Net Profit | $4.5M | $72.8M |
| Gross Margin | — | — |
| Operating Margin | — | 10.9% |
| Net Margin | 0.5% | 7.4% |
| Revenue YoY | 7.5% | 10.8% |
| Net Profit YoY | -50.8% | -7.5% |
| EPS (diluted) | $0.05 | $1.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | $982.9M | ||
| Q4 25 | $821.5M | $962.7M | ||
| Q3 25 | $851.6M | $961.1M | ||
| Q2 25 | $869.2M | $966.0M | ||
| Q1 25 | $770.5M | $887.3M | ||
| Q4 24 | $774.2M | $848.1M | ||
| Q3 24 | $815.6M | $909.3M | ||
| Q2 24 | $796.0M | $910.1M |
| Q1 26 | $4.5M | $72.8M | ||
| Q4 25 | $-1.2B | $74.3M | ||
| Q3 25 | $36.2M | $127.9M | ||
| Q2 25 | $30.1M | $111.7M | ||
| Q1 25 | $8.4M | $78.8M | ||
| Q4 24 | $32.6M | $100.9M | ||
| Q3 24 | $68.1M | $100.0M | ||
| Q2 24 | $78.5M | $90.5M |
| Q1 26 | — | 10.9% | ||
| Q4 25 | -142.4% | 11.0% | ||
| Q3 25 | 4.7% | 14.2% | ||
| Q2 25 | 5.8% | 14.9% | ||
| Q1 25 | 1.7% | 12.8% | ||
| Q4 24 | 4.9% | 14.2% | ||
| Q3 24 | 12.1% | 15.2% | ||
| Q2 24 | 13.4% | 13.8% |
| Q1 26 | 0.5% | 7.4% | ||
| Q4 25 | -143.3% | 7.7% | ||
| Q3 25 | 4.3% | 13.3% | ||
| Q2 25 | 3.5% | 11.6% | ||
| Q1 25 | 1.1% | 8.9% | ||
| Q4 24 | 4.2% | 11.9% | ||
| Q3 24 | 8.4% | 11.0% | ||
| Q2 24 | 9.9% | 9.9% |
| Q1 26 | $0.05 | $1.12 | ||
| Q4 25 | $-12.98 | $1.13 | ||
| Q3 25 | $0.40 | $1.92 | ||
| Q2 25 | $0.33 | $1.67 | ||
| Q1 25 | $0.09 | $1.17 | ||
| Q4 24 | $0.36 | $1.48 | ||
| Q3 24 | $0.74 | $1.48 | ||
| Q2 24 | $0.85 | $1.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $229.5M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $2.6B |
| Total Assets | $5.5B | $5.1B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | $229.5M | ||
| Q4 25 | $133.2M | $409.5M | ||
| Q3 25 | $118.7M | $264.8M | ||
| Q2 25 | $131.4M | $169.8M | ||
| Q1 25 | $91.2M | $136.8M | ||
| Q4 24 | $76.3M | $226.2M | ||
| Q3 24 | $82.1M | $327.9M | ||
| Q2 24 | $77.2M | $223.9M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $1.1B | ||
| Q3 25 | $2.3B | $546.0M | ||
| Q2 25 | $2.3B | $535.1M | ||
| Q1 25 | $2.2B | $561.2M | ||
| Q4 24 | $2.0B | $688.1M | ||
| Q3 24 | $1.9B | $822.7M | ||
| Q2 24 | $1.8B | $681.5M |
| Q1 26 | $2.0B | $2.6B | ||
| Q4 25 | $1.9B | $2.7B | ||
| Q3 25 | $3.1B | $2.8B | ||
| Q2 25 | $3.1B | $2.7B | ||
| Q1 25 | $3.0B | $2.5B | ||
| Q4 24 | $3.1B | $2.5B | ||
| Q3 24 | $3.0B | $2.5B | ||
| Q2 24 | $3.0B | $2.4B |
| Q1 26 | $5.5B | $5.1B | ||
| Q4 25 | $5.5B | $5.3B | ||
| Q3 25 | $6.4B | $5.1B | ||
| Q2 25 | $6.3B | $4.9B | ||
| Q1 25 | $6.1B | $4.5B | ||
| Q4 24 | $6.0B | $4.4B | ||
| Q3 24 | $5.9B | $4.6B | ||
| Q2 24 | $5.7B | $4.5B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.43× | ||
| Q3 25 | 0.74× | 0.20× | ||
| Q2 25 | 0.74× | 0.20× | ||
| Q1 25 | 0.72× | 0.22× | ||
| Q4 24 | 0.64× | 0.28× | ||
| Q3 24 | 0.62× | 0.32× | ||
| Q2 24 | 0.62× | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | — |
| Free Cash FlowOCF − Capex | — | $53.3M |
| FCF MarginFCF / Revenue | — | 5.4% |
| Capex IntensityCapex / Revenue | — | 6.7% |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $327.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $183.7M | ||
| Q3 25 | $73.2M | $177.6M | ||
| Q2 25 | $133.5M | $126.0M | ||
| Q1 25 | $11.5M | $82.7M | ||
| Q4 24 | $116.7M | $178.2M | ||
| Q3 24 | $163.1M | $229.3M | ||
| Q2 24 | $171.1M | $143.6M |
| Q1 26 | — | $53.3M | ||
| Q4 25 | $-179.5M | $96.9M | ||
| Q3 25 | $-63.0M | $114.3M | ||
| Q2 25 | $-34.2M | $62.5M | ||
| Q1 25 | $-163.2M | $25.9M | ||
| Q4 24 | $-86.8M | $112.2M | ||
| Q3 24 | $-27.1M | $162.7M | ||
| Q2 24 | $16.9M | $75.4M |
| Q1 26 | — | 5.4% | ||
| Q4 25 | -21.8% | 10.1% | ||
| Q3 25 | -7.4% | 11.9% | ||
| Q2 25 | -3.9% | 6.5% | ||
| Q1 25 | -21.2% | 2.9% | ||
| Q4 24 | -11.2% | 13.2% | ||
| Q3 24 | -3.3% | 17.9% | ||
| Q2 24 | 2.1% | 8.3% |
| Q1 26 | — | 6.7% | ||
| Q4 25 | 11.3% | 9.0% | ||
| Q3 25 | 16.0% | 6.6% | ||
| Q2 25 | 19.3% | 6.6% | ||
| Q1 25 | 22.7% | 6.4% | ||
| Q4 24 | 26.3% | 7.8% | ||
| Q3 24 | 23.3% | 7.3% | ||
| Q2 24 | 19.4% | 7.5% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 2.47× | ||
| Q3 25 | 2.02× | 1.39× | ||
| Q2 25 | 4.43× | 1.13× | ||
| Q1 25 | 1.37× | 1.05× | ||
| Q4 24 | 3.58× | 1.77× | ||
| Q3 24 | 2.39× | 2.29× | ||
| Q2 24 | 2.18× | 1.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
ATR
Segment breakdown not available.
